Multiple myeloma (MM) is a life-threatening hematological malignancy. High-dose chemotherapy followed by autologous stem cell transplantation is a relatively effective treatment, but disease ...

Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease drug has been rocked by a phase 2 flop. | Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease ...

In a recent study published in the Journal of Allergy and Clinical Immunology, a team of researchers from the United States (U.S.) investigated the impact of a monoclonal anti-thymic stromal ...

A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving ...

The approval marks the first for a targeted treatment in chronic spontaneous urticaria in Europe in over a decad ...

Advances in the development of monoclonal antibodies have led to new agents rapidly incorporated into standard lymphoma therapy. The characteristics of the target antigen and the properties of the ...

New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal ...

Market OverviewThe global Cancer Immunotherapy Market is valued at USD 121.4 Billion in 2024 and is projected to reach a value of USD 294.4 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 8 ...

If you’ve tried other multiple myeloma treatments and they’re not working, your doctor may suggest immunotherapy. One type of immunotherapy uses monoclonal antibodies made in a lab to boost your ...

The JS001sc-002-III-NSCLC Study is a multi-center, open-label, randomized Phase 3 clinical study led by the principal investigator Professor Lin WU from Hunan Cancer Hospital. JS001sc-002-III-NSCLC is ...

Please provide your email address to receive an email when new articles are posted on . A single dose of Regeneron’s REGN1908/1909 significantly prevented reductions in FEV1 compared with placebo.

Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the ...